Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GemBex phase II study in cutaneous T-cell lymphoma
2006-000591-33Phase 2Completed
- Sponsor
- University College London
- Start
- Mar 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine and bexarotene in cutaneous T-cell lymphoma (CTCL), sponsored by University College London. Started Mar 2006; status: completed.
02
Drugs
gemcitabinebexarotene
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on 2006-000591-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000591-33.